Octreotide Acetate Microspheres 30mg Injection by Cordium Pharmaceuticals Pvt Ltd
Octreotide Acetate Microspheres 30mg Injection is a long-acting somatostatin analogue formulated using biodegradable microsphere technology that enables sustained drug release over approximately four weeks. It is commonly prescribed for the management of acromegaly, gastroenteropancreatic neuroendocrine tumors (NETs), carcinoid syndrome, and other hormone-secreting tumors under specialist supervision. Long-acting octreotide depot injections are widely recognized in international clinical practice for monthly intramuscular administration.
Cordium Pharmaceuticals Pvt Ltd supplies high-quality pharmaceutical formulations for hospitals, specialty clinics, oncology centers, institutional buyers, licensed pharmaceutical distributors, and eligible personal import patients worldwide.
Product Overview
Product Name: Octreotide Acetate Microspheres 30mg Injection
Strength: 30 mg
Dosage Form: Long-Acting Injectable Suspension
Administration: Intramuscular injection by qualified healthcare professionals
Packaging: Sterile single-dose vial with diluent
Manufacturer: Cordium Pharmaceuticals Pvt Ltd
Therapeutic Applications
Octreotide Acetate Microspheres 30mg Injection may be prescribed for:
Acromegaly
Gastroenteropancreatic Neuroendocrine Tumors (NETs)
Carcinoid Syndrome
Hormone-secreting endocrine tumors
Symptom management associated with excessive hormone production
Treatment should always be initiated and monitored by a qualified healthcare professional according to local prescribing guidelines.
Advantages of Long-Acting Microsphere Technology
Sustained drug release over approximately 4 weeks
Reduced injection frequency
Consistent therapeutic drug levels
Improved treatment adherence
Designed for hospital and specialty clinic administration
Global Export Markets
Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical supply across international markets, including:
USA
United Kingdom
UAE
South Africa
Singapore
Australia
Canada
Germany
The company works with:
Hospitals
Oncology Centers
Endocrinology Clinics
Government Procurement Agencies
Pharmaceutical Distributors
Wholesalers
International Importers
Healthcare Institutions
Personal Import Support
Where permitted by local regulations, Cordium Pharmaceuticals Pvt Ltd can assist eligible patients seeking personal import of Octreotide Acetate Microspheres 30mg Injection.
Patients may require:
Valid physician prescription
Medical documentation
Country-specific import approvals
Compliance with customs and healthcare regulations
Import eligibility varies by country and should be verified before shipment.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Reliable pharmaceutical manufacturer
International export capabilities
Consistent product quality
Professional export documentation
Bulk order support
Institutional supply solutions
Distributor partnership opportunities
Responsive customer support
Available Export Services
Cordium Pharmaceuticals Pvt Ltd offers:
Commercial export
Hospital supply
Government tenders
Third-party manufacturing
Contract manufacturing
Private labeling
International logistics support
Documentation assistance
Frequently Asked Questions
What is Octreotide Acetate Microspheres 30mg Injection used for?
It is prescribed by specialists for conditions including acromegaly and selected neuroendocrine tumors requiring long-acting somatostatin analogue therapy.
How often is it administered?
Long-acting octreotide microsphere formulations are generally administered once every four weeks by intramuscular injection, according to the treating physician's instructions.
Can hospitals purchase in bulk?
Yes. Hospitals, institutional buyers, and licensed pharmaceutical distributors may inquire about bulk procurement and long-term supply agreements.
Is international export available?
Yes. Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical exports, subject to regulatory compliance and import requirements.
Is personal import possible?
Eligible patients may be able to import the medicine where local laws permit, subject to prescription and applicable regulatory requirements.
Octreotide Acetate Microspheres 30mg Injection is a long-acting somatostatin analogue formulated using biodegradable microsphere technology that enables sustained drug release over approximately four weeks. It is commonly prescribed for the management of acromegaly, gastroenteropancreatic neuroendocrine tumors (NETs), carcinoid syndrome, and other hormone-secreting tumors under specialist supervision. Long-acting octreotide depot injections are widely recognized in international clinical practice for monthly intramuscular administration.
Cordium Pharmaceuticals Pvt Ltd supplies high-quality pharmaceutical formulations for hospitals, specialty clinics, oncology centers, institutional buyers, licensed pharmaceutical distributors, and eligible personal import patients worldwide.
Product Overview
Product Name: Octreotide Acetate Microspheres 30mg Injection
Strength: 30 mg
Dosage Form: Long-Acting Injectable Suspension
Administration: Intramuscular injection by qualified healthcare professionals
Packaging: Sterile single-dose vial with diluent
Manufacturer: Cordium Pharmaceuticals Pvt Ltd
Therapeutic Applications
Octreotide Acetate Microspheres 30mg Injection may be prescribed for:
Acromegaly
Gastroenteropancreatic Neuroendocrine Tumors (NETs)
Carcinoid Syndrome
Hormone-secreting endocrine tumors
Symptom management associated with excessive hormone production
Treatment should always be initiated and monitored by a qualified healthcare professional according to local prescribing guidelines.
Advantages of Long-Acting Microsphere Technology
Sustained drug release over approximately 4 weeks
Reduced injection frequency
Consistent therapeutic drug levels
Improved treatment adherence
Designed for hospital and specialty clinic administration
Global Export Markets
Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical supply across international markets, including:
USA
United Kingdom
UAE
South Africa
Singapore
Australia
Canada
Germany
The company works with:
Hospitals
Oncology Centers
Endocrinology Clinics
Government Procurement Agencies
Pharmaceutical Distributors
Wholesalers
International Importers
Healthcare Institutions
Personal Import Support
Where permitted by local regulations, Cordium Pharmaceuticals Pvt Ltd can assist eligible patients seeking personal import of Octreotide Acetate Microspheres 30mg Injection.
Patients may require:
Valid physician prescription
Medical documentation
Country-specific import approvals
Compliance with customs and healthcare regulations
Import eligibility varies by country and should be verified before shipment.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Reliable pharmaceutical manufacturer
International export capabilities
Consistent product quality
Professional export documentation
Bulk order support
Institutional supply solutions
Distributor partnership opportunities
Responsive customer support
Available Export Services
Cordium Pharmaceuticals Pvt Ltd offers:
Commercial export
Hospital supply
Government tenders
Third-party manufacturing
Contract manufacturing
Private labeling
International logistics support
Documentation assistance
Frequently Asked Questions
What is Octreotide Acetate Microspheres 30mg Injection used for?
It is prescribed by specialists for conditions including acromegaly and selected neuroendocrine tumors requiring long-acting somatostatin analogue therapy.
How often is it administered?
Long-acting octreotide microsphere formulations are generally administered once every four weeks by intramuscular injection, according to the treating physician's instructions.
Can hospitals purchase in bulk?
Yes. Hospitals, institutional buyers, and licensed pharmaceutical distributors may inquire about bulk procurement and long-term supply agreements.
Is international export available?
Yes. Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical exports, subject to regulatory compliance and import requirements.
Is personal import possible?
Eligible patients may be able to import the medicine where local laws permit, subject to prescription and applicable regulatory requirements.
Keywords
